Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray

NCT01567670 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: Naloxone
DRUG: naloxone placebo

Sponsor

Lightlake Sinclair Ltd.